Etanercept-Induced Crohn’s Disease in Ankylosing Spondylitis: A Case Report - Abstract
We present the case of a young male patient who developed Crohn’s disease (CD) following Etanercept (ETN) treatment for ankylosing spondylitis (AS). After 1 month of abdominal pain, diarrhea, fever, and weight loss ETN treatment was stopped and treatment with infliximab (IFX) begun. The patient responded well and was discharged from the hospital. New-onset CD is an immune-mediated injury induced by ETN treatment. However, a definitive causative link between ETN and CD has not yet been established.